Structured treatment of gastroesophageal reflux in a company health care setting, -effect on quality of life, symptoms and productivity
Study identifier:NIS-GSE-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A prospective, non interventional study to evaluate the effects on quality of life, symptoms and productivity in patients with gastroesophageal reflux disease (GERD) after 6 weeks structured treatment in a company health care setting
Medical condition
GERD
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
36
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Apr 2009
Primary Completion Date: -
Study Completion Date: 01 Jun 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Svante Sjöstedt
AstraZeneca Sweden
